Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavir.

Esteban Martínez; Pere Domingo; María J Galindo; Ana Milinkovic; Juan A Arroyo; Francisco Baldovi; María Larrousse; Agathe León; Elisa de Lazzari; José M Gatell

doi:10.1086/382531

Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavir.

Identifier:nobleid.org/w1/20260515/D9DA8B70

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D9DA8B70.svg?ark=w1%2F20260515%2FD9DA8B70)](https://nobleid.org/work/w1/20260515/D9DA8B70)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavir.

Identifier:nobleid.org/w1/20260515/D9DA8B70

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D9DA8B70.svg?ark=w1%2F20260515%2FD9DA8B70)](https://nobleid.org/work/w1/20260515/D9DA8B70)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work